Skip to main content

Live Olema Oncology, Inc. Common Stock Share Price Chart

O 7.015H 7.015L 7.015

Olema Oncology, Inc. Common Stock Performance Overview

Days Range
▼
$7.01Low
$7.33High

Markets Today

Previous Close$7.15
Open$7.01
Volume835,306
Day's Range$7.01 - $7.33
52W Range$6.24 - $36.26
Market Cap$618.50 M

Historical Performance

1M Returns-1.38
3M Returns-34.40
6M Returns-48.78
1Y Returns-67.51
5Y Returns-68.59
10Y ReturnsNA

Olema Oncology, Inc. Common Stock Fundamentals

Market Cap$618.50 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.37
EPS TTM$-2.35
Quarterly Earnings Growth YOYN/A
PB Ratio1.37
EBITDA$-178.21 M
Profit MarginN/A
Market Cap$618.50 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.37
EPS TTM$-2.35
Quarterly Earnings Growth YOYN/A
PB Ratio1.37
EBITDA$-178.21 M
Profit MarginN/A

Olema Oncology, Inc. Common Stock Profit & Loss

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$47.86 M-$45.88 M-$50.08 M-$57.99 M-$67.18 M-$77.53 M
EBITDA -$47.73 M-$45.83 M-$49.90 M-$57.87 M-$67.08 M-$77.43 M
Interest Expense $38.00 K$0$0$0-$528.00 K$0
Depreciation $132.00 K$43.00 K$187.00 K$119.00 K$102.00 K$94.00 K
Income Before Tax -$43.78 M-$42.22 M-$46.06 M-$53.09 M-$63.20 M-$73.60 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$43.78 M-$42.22 M-$46.06 M-$53.09 M-$63.20 M-$73.60 M
Net Profit Margin ------

Olema Oncology, Inc. Common Stock Financials Balance Sheet In USD

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Share Capital $7.00 K$7.00 K$8.00 K$8.00 K$8.00 K$8.00 K
Reserve & Surplus -$508.96 M-$550.97 M-$596.94 M-$651.11 M-$714.79 M-$789.04 M
Non-Current Liabilities $3.60 M$3.31 M$3.07 M$3.00 M$3.00 M$3.00 M
Current Liabilities $33.16 M$41.66 M$51.80 M$47.17 M$53.01 M$69.23 M
Total Liabilities $36.77 M$44.97 M$54.87 M$50.17 M$56.01 M$72.23 M
Fixed Assets $0$0$0$0$0$0
Current Assets $367.73 M$334.33 M$515.45 M$513.23 M$469.88 M$423.43 M
Total Assets $382.00 M$352.45 M$533.43 M$530.64 M$486.58 M$441.07 M

Olema Oncology, Inc. Common Stock Cash Flow

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Net Income -$43.78 M-$42.22 M-$46.06 M-$53.09 M-$63.20 M-$73.60 M
Operating Cash Flow -$29.88 M-$34.53 M-$38.33 M-$45.99 M-$45.90 M-$47.11 M
Investing Cash Flow $34.23 M$17.27 M-$162.18 M$4.53 M$40.84 M$45.60 M
Financing Cash Flow -$2.52 M$41.00 K$213.55 M$45.70 M$1.11 M$434.00 K
Change in Cash $1.83 M-$17.21 M$13.04 M$4.25 M-$3.95 M-$1.08 M

Olema Oncology, Inc. Common Stock Return Calculator

The Olema Oncology, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$3,067
Invested Amount$10,000
Est. Returns$-6,933
Invest in USA Stock Today

About Olema Oncology, Inc. Common Stock

Olema Oncology Inc is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. Olema is advancing a pipeline of novel therapies by leveraging its deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance. The company's lead product candidate, palazestrant (OP-1250), is a proprietary, orally available complete estrogen receptor antagonist (CERAN) and a selective estrogen receptor degrader (SERD), is currently in two Phase 3 clinical trials. In addition, Olema is focused in developing OP-3136, a potent lysine acetyltransferase 6 (KAT6) inhibitor.

FAQs

Olema Oncology, Inc. Common Stock (OLMA) share price as of November 20, 2026 is $6.98. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Olema Oncology, Inc. Common Stock (OLMA) Share by opening an international trading account with Angel One.
Purchasing Olema Oncology, Inc. Common Stock (OLMA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Olema Oncology, Inc. Common Stock (OLMA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Olema Oncology, Inc. Common Stock (OLMA) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Olema Oncology, Inc. Common Stock on November 20, 2026, is $618.50 M.
Olema Oncology, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Olema Oncology, Inc. Common Stock (OLMA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.